vesna cukic, aida ustamujic


Introduction: Malignant diseases including lung cancer are the risk for development of deep venous thrombosis (DVT)  and pulmonary thromboembolism (PTE).                                                                               Objective:  To show the number of DVT in patients with lung cancer treated in Clinic for pulmonary diseases and TB “Podhrastovi” in three-year period: from 2012-2014.                                                          Material and methods: This is the retrospective study in which we present the number of various types of lung cancer treated in three-year period in Clinic”Podhrastovi”, number and per cent of DVT in different types of lung carcinoma, number and per cent of DVT of all diagnosed DVT in lung carcinoma according to the type of carcinoma. Results: In three-year period (from 2012. to 2014.year)   1609 patients with lung cancer were treated in Clinic for pulmonary diseases and TB “Podhrastovi” Clinical Centre of Sarajevo University. 26 patients: 20 men middle –aged 59.9 years   and 6 women middle- aged 63.1 years or   1.62 % of all patients with lung cancer had diagnosed DVT.  Of all 26 patients with lung cancer and diagnosed DVT   3 patients   (11.53%) had planocellular cancer, 1 patient (3.85%) had squamocellular cancer, 13 (50%) had adenocarcinoma, 2 (7.7 %) had NSCLC, 1 (3.65 %) had microcellular cancer, 6 (23.08%) had histological non-differentiated lung carcinoma.                                                                                                                             Conclusion: Malignant diseases, including lung cancer, are the risk factor for development of DVT. It is important to consider the including anticoagulant prophylaxis in these patients and so to slow down the course of diseases in these patients.                                                                      


lung cancer, deep venous thrombosis

DOI: 10.5457/ams.v43i1 - 2.363